A novel mRNA-based patient selection strategy identifies fibroblast growth factor receptor (FGFR) inhibitor-sensitive tumors: Results from rogaratinib Phase-1 study

Joerger, M; Soo, RA; Cho, BC; Navarro, A; Sayehli, CM; Richly, H; Tai, D; Kim, DW; Wolf, J; Cassier, P; Bender, S; Ellinghaus, P; Ince, S; Rajagopalan, P; Ocker, M; Schuler, M

ANNALS OF ONCOLOGY, 2017; 28 ( ):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索